MedPath

Detecting Multiple Sclerosis via breath analysis using an eNose

Recruiting
Conditions
Multiple Sclerosis
Registration Number
NL-OMON26204
Lead Sponsor
Drs. M.W.P.M. Lenders
Brief Summary

Ettema A.R, et al. Detecting Multiple Sclerosis via breath analysis using an eNose, a pilot study. J. Breath Res. 2021, 15, 027101

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

Inclusion criteria for patients with MS:
- Diagnosis MS confirmed by a neurologist
- Age >18 years

Inclusion criteria control subjects
- Not suspicious of having MS
- Age >18 years

Exclusion Criteria

- Physically or cognitively being unable to use the Aeonose
- Diagnosed with another neurodegenerative or neuroinflammatory disease (besides MS)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Investigate the accuracy of the AeonoseTM in distinguishing breath prints of patients with various types and stages of MS and sujects without MS, whether it can assist in diagnosing MS, and whether it can monitor its progression.
Secondary Outcome Measures
NameTimeMethod
1.Improve the model created in the pilot study by expanding the groups.<br>2.Determine whether eNose patterns differ for various types and stages of MS. <br>3.Determine whether eNose patterns differ between MS patients with a positive response to medication and MS patients with no response to medication, to predict and monitor the patients response to treatment. <br>4.Determine whether our eNose models are able to distinguish between subjects who will be diagnosed with MS and those who will not get the diagnosis MS.
© Copyright 2025. All Rights Reserved by MedPath